07/10/2025
4:14 PM | Agios Pharmaceuticals (Subject)
Scadden David (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/10/2025
3:14 PM | Agios Pharmaceuticals (Issuer)
Backstrom Jay T. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/09/2025
3:59 PM | Agios Pharmaceuticals (Subject)
Gheuens Sarah (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/08/2025
6:01 AM | Agios Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/07/2025
6:32 PM | Agios Pharmaceuticals (Subject)
Bellevue Group AG (Filed by)
| Form SCHEDULE 13G | |
06/26/2025
4:22 PM | Agios Pharmaceuticals (Issuer)
Goff Brian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2025
4:23 PM | Agios Pharmaceuticals (Issuer)
Milanova Tsveta (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2025
4:24 PM | Agios Pharmaceuticals (Issuer)
Jones Cecilia (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2025
4:25 PM | Agios Pharmaceuticals (Issuer)
Gheuens Sarah (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2025
4:26 PM | Agios Pharmaceuticals (Issuer)
Burns James William (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/24/2025
3:01 PM | Agios Pharmaceuticals (Subject)
Burns James William (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Get the Latest News and Ratings for AGIO and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Agios Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. |
06/24/2025
3:05 PM | Agios Pharmaceuticals (Subject)
Gheuens Sarah (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/23/2025
3:17 PM | Agios Pharmaceuticals (Issuer)
Smith Cynthia (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2025
3:18 PM | Agios Pharmaceuticals (Issuer)
Scadden David (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2025
3:20 PM | Agios Pharmaceuticals (Issuer)
Owen Adams Catherine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2025
3:21 PM | Agios Pharmaceuticals (Issuer)
Ho Maykin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2025
3:23 PM | Agios Pharmaceuticals (Issuer)
FOUSE JACQUALYN A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2025
3:24 PM | Agios Pharmaceuticals (Issuer)
Foster-Cheek Kaye I (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2025
3:25 PM | Agios Pharmaceuticals (Issuer)
CAPELLO JEFFREY D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2025
3:27 PM | Agios Pharmaceuticals (Issuer)
Ballal Rahul D. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2025
3:41 PM | Agios Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
06/18/2025
3:31 PM | Agios Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/13/2025
1:50 PM | Agios Pharmaceuticals (Subject)
BB BIOTECH AG (Filed by)
| Form SCHEDULE 13G/A | |
05/01/2025
9:26 AM | Agios Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/01/2025
5:32 AM | Agios Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/10/2025
3:02 PM | Agios Pharmaceuticals (Issuer)
FOUSE JACQUALYN A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/08/2025
4:58 PM | Agios Pharmaceuticals (Subject)
FOUSE JACQUALYN A (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/07/2025
3:15 PM | Agios Pharmaceuticals (Issuer)
Viswanadhan Krishnan (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
03/07/2025
3:18 PM | Agios Pharmaceuticals (Issuer)
Viswanadhan Krishnan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2025
4:27 PM | Agios Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/04/2025
3:12 PM | Agios Pharmaceuticals (Issuer)
Milanova Tsveta (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/03/2025
3:42 PM | Agios Pharmaceuticals (Subject)
Burns James William (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/03/2025
3:44 PM | Agios Pharmaceuticals (Subject)
Gheuens Sarah (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/03/2025
3:46 PM | Agios Pharmaceuticals (Subject)
Goff Brian (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/03/2025
3:49 PM | Agios Pharmaceuticals (Subject)
Jones Cecilia (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/03/2025
3:50 PM | Agios Pharmaceuticals (Subject)
Milanova Tsveta (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/14/2025
1:35 PM | Agios Pharmaceuticals (Subject)
BB BIOTECH AG (Filed by)
| Form SCHEDULE 13G/A | |
02/13/2025
8:26 AM | Agios Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/13/2025
5:32 AM | Agios Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/13/2025
5:01 AM | Agios Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/04/2025
11:02 AM | Agios Pharmaceuticals (Subject)
Farallon Capital Partners, L.P. (Filed by)
| Form SCHEDULE 13G/A | |
Which Gold Miner Trades at 30% of NAV? The One Buffett Wants (Ad) Some of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents.
With gold at record highs and Bridgewater now buying in, one analyst believes Buffett’s next move could hit by August 15th. He’s identified the gold miner that fits Buffett’s profile — plus four smaller plays with even more upside. Get the name of Buffett’s likely gold target here |
01/13/2025
6:01 AM | Agios Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/07/2025
4:05 PM | Agios Pharmaceuticals (Issuer)
Milanova Tsveta (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
5:36 AM | Agios Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/13/2024
3:14 PM | Agios Pharmaceuticals (Issuer)
Washburn Theodore James Jr. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/08/2024
3:17 PM | Agios Pharmaceuticals (Subject)
Ballal Rahul D. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/08/2024
1:40 PM | Agios Pharmaceuticals (Subject)
Farallon Capital Partners, L.P. (Filed by)
| Form SC 13G/A | |
10/31/2024
8:20 AM | Agios Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/31/2024
5:56 AM | Agios Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/30/2024
3:15 PM | Agios Pharmaceuticals (Issuer)
Jones Cecilia (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/13/2024
3:12 PM | Agios Pharmaceuticals (Issuer)
Smith Cynthia (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/13/2024
3:15 PM | Agios Pharmaceuticals (Issuer)
Ballal Rahul D. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/12/2024
4:15 PM | Agios Pharmaceuticals (Issuer)
Goff Brian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/01/2024
8:49 AM | Agios Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/01/2024
6:03 AM | Agios Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Free AGIO Stock Alerts